PreciQube builds quantum‑enabled diagnostic systems that use quantum‑enhanced optical sensing to detect ultra‑weak molecular signatures of early‑stage cancer. The platform provides label‑free, non‑invasive, reagent‑free measurements with compact, low‑cost hardware, allowing safe repeated screening without radiation or dyes.
Funding
Funding not disclosed
Founders
Product
Problem
India’s cancer screening infrastructure provides coverage to less than 2% of high‑risk individuals, leaving millions without early detection. Existing screening methods are invasive, expensive, and require complex equipment, making large‑scale routine testing impractical.
Solution
PreciQube develops diagnostic systems that apply quantum‑enhanced optical sensing to identify ultra‑weak molecular signatures associated with early‑stage cancer. The technology delivers label‑free, non‑invasive measurements that do not require reagents or radiation, enabling safe repeated use. By amplifying signals that are normally buried in noise, the platform can detect disease earlier than conventional assays. The design emphasizes low‑cost optical components and scalable manufacturing, targeting affordable deployment across India’s high‑risk populations. Clinical validation and stakeholder engagement are ongoing to ensure reliability and regulatory compliance.
Target Audience
Primary customers are public health programs, large‑scale screening providers, and healthcare networks in India that serve high‑risk populations requiring affordable, repeatable cancer diagnostics.
Features
- Quantum‑enhanced optical sensing that amplifies ultra‑weak biochemical signals for early disease detection
- Label‑free measurement eliminates the need for contrast agents, dyes, or radioactive tracers
- Non‑invasive, reagent‑free workflow suitable for repeated screening without patient discomfort
- Compact optical hardware designed for low manufacturing cost and easy deployment in community settings
- Real‑time data acquisition and analysis pipeline that operates without extensive laboratory infrastructure